MétaCan
Menu
Back to cohort
Record W4389476609 · doi:10.1002/ehf2.14604

Guideline Implementation, Drug Sequencing, and Quality of Care in Heart Failure: Design and Rationale of TITRATE-HF

2023· article· en· W4389476609 on OpenAlexaboutno aff
Pascal R.D. Clephas, Jishnu Malgie, Jeroen Schaap, Stefan Koudstaal, Mireille E. Emans, Gerard C.M. Linssen, Grytsje A. de Boer, Loek van Heerebeek, C. Jan Willem Borleffs, Olivier C. Manintveld, Vanessa van Empel, Sandra van Wijk, Mieke van den Heuvel, Carlos Fonseca, Kevin Damman, Jan van Ramshorst, Roland van Kimmenade, Arjen R. T. van de Ven, René A. Tio, Dennis van Veghel, Folkert W. Asselbergs, Rudolf A. de Boer, Peter van der Meer, Stephen J. Greene, Hans‐Peter Brunner‐La Rocca, Jasper J. Brugts

Bibliographic record

VenueESC Heart Failure · 2023
Typearticle
Languageen
FieldMedicine
TopicHeart Failure Treatment and Management
Canadian institutionsnot available
FundersNetherlands Heart InstituteICIN Netherlands Heart InstituteNovo NordiskCytokineticsDutch Cardiovascular AllianceIonis PharmaceuticalsNovartisBayerBristol-Myers SquibbEli Lilly and CompanyAstraZenecaVifor PharmaPfizerBoehringer IngelheimAmgenSanofiAmerican Heart AssociationAbbott Laboratories
KeywordsMedicineEjection fractionGuidelineHeart failureIntensive care medicineCanadian Cardiovascular SocietyClinical PracticeInternal medicineCardiologyPhysical therapyPathology

Abstract

fetched live from OpenAlex

AIMS: Current heart failure (HF) guidelines recommend to prescribe four drug classes in patients with HF with reduced ejection fraction (HFrEF). A clear challenge exists to adequately implement guideline-directed medical therapy (GDMT) regarding the sequencing of drugs and timely reaching target dose. It is largely unknown how the paradigm shift from a serial and sequential approach for drug therapy to early parallel application of the four drug classes will be executed in daily clinical practice, as well as the reason clinicians may not adhere to new guidelines. We present the design and rationale for the real-world TITRATE-HF study, which aims to assess sequencing strategies for GDMT initiation, dose titration patterns (order and speed), intolerance for GDMT, barriers for implementation, and long-term outcomes in patients with de novo, chronic, and worsening HF. METHODS AND RESULTS: A total of 4000 patients with HFrEF, HF with mildly reduced ejection fraction, and HF with improved ejection fraction will be enrolled in >40 Dutch centres with a follow-up of at least 3 years. Data collection will include demographics, physical examination and vital parameters, electrocardiogram, laboratory measurements, echocardiogram, medication, and quality of life. Detailed information on titration steps will be collected for the four GDMT drug classes. Information will include date, primary reason for change, and potential intolerances. The primary clinical endpoints are HF-related hospitalizations, HF-related urgent visits with a need for intravenous diuretics, all-cause mortality, and cardiovascular mortality. CONCLUSIONS: TITRATE-HF is a real-world multicentre longitudinal registry that will provide unique information on contemporary GDMT implementation, sequencing strategies (order and speed), and prognosis in de novo, worsening, and chronic HF patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.206
metaresearch head score (Gemma)0.174
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.206
Threshold uncertainty score0.979

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2060.174
Meta-epidemiology (narrow)0.0020.002
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0020.001
Science and technology studies0.0020.005
Scholarly communication0.0030.003
Open science0.0030.004
Research integrity0.0040.003
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.043
GPT teacher head0.349
Teacher spread0.306 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designTheoretical or conceptual
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations12
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueESC Heart FailureSame topicHeart Failure Treatment and ManagementFrench-language works237,207